Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by Longholder99on Oct 28, 2024 10:09am

RE:RE:Level II Quotes

It was my belief that a warrant does cause dilution in that the warrant becomes a share and part of circulation once the owner of the warrant exercises.  The current sp being the differential ...more  
220
Discussion
Comment by reconsideron Oct 28, 2024 10:06am

RE:RE:RE:Another raise hahaha

"This is a quick offering as we are not looking to do a large raise at this time. We feel that we will be able to do a larger capital raise early 2025 at a higher valuation." Sounds good to ...more  
235
Discussion
Comment by managementfirston Oct 28, 2024 10:00am

RE:Could not resist.

very insightful words!!
123
Discussion
Comment by jicoopon Oct 28, 2024 9:46am

RE:Level II Quotes

and right on cue, the big lot ask has been moved down from .54 to .36 this morning. Games people play. Guess raise is required, too bad insiders could not pony up and excercise some of the .25 options ...more  
200
Discussion
Post by knoxton Oct 28, 2024 9:34am

Level II Quotes

TLT :CA TSX VENTURE THERALASE TECHNOLOGIES INC Current price0.265Day’s price change-0.025day’s price change (-8.62 ...more  
206
Discussion
Comment by TommyNickelson Oct 28, 2024 9:31am

RE:RE:RE:Another raise hahaha

How far along will 1 million Canadian taken them? This is sufficient cash to treat another 25 patients?? And to start Toxicology?
121
Discussion
Comment by Paradise818on Oct 28, 2024 9:29am

RE:Could not resist.

Another reincarnation of Tommyboy.  Ignored.
125
Discussion
Comment by DeathXray33on Oct 28, 2024 9:25am

RE:RE:RE:RE:Per 012009

Moderna: "The stock has dropped 46% so far this year and 56% in the past three months" Merck: down 19% in three months.
145
Discussion
Post by knoxton Oct 28, 2024 9:23am

premarket

All modification requests are subject to prior fill. If your order has already been filled when your request reaches the exchange, your modification request may be rejected."},"TOOLTIP" ...more  
183
Post by Maxcitracon Oct 28, 2024 9:22am

Could not resist.

I have been watching this little company for a time. Will try to get as much shares a my small budget permit, before this Kraken monster get going. From my observations, I came to the conclusion, TLT ...more  
330
Discussion
Comment by SmartldorfBlackon Oct 28, 2024 9:05am

RE:RE:RE:Another raise hahaha

So if u got a letter why u out here trying to act all ambiguous like you gotta spread fear for some reason? Sounds like you got a copy so what was the point of ur last post? Stop talking? Take ur own ...more  
179
Discussion
Comment by Dumbeldorfwhiteon Oct 28, 2024 8:56am

RE:RE:Another raise hahaha

Just stop talking man Theralase® has commenced a non-brokered private placement to raise up to $CAN 1 M to close early November. Please see below for details of the private placement. The private ...more  
217
Discussion
Comment by SmartldorfBlackon Oct 28, 2024 8:19am

RE:Another raise hahaha

How many times do we gotta go thru this fam they only send emails if you have actual shares in the company Bro literally asked who got the email like he got an email then immediately has to guess ...more  
195
Discussion
Comment by Beano349on Oct 28, 2024 8:10am

RE:RE:Another raise hahaha

Sounds like the normal cash raise that happened every 2 months or so.  You will see a PR when it closes. 
128
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250